Fig. 1
From: Metabolic reprogramming in the tumor microenvironment of liver cancer
Metabolic alterations in PLC. HBV: hepatitis B virus; HCV: hepatitis C virus; MASH: metabolic dysfunction-associated steatohepatitis; MASLD: metabolic dysfunction-associated steatotic liver disease; OE: overexpression; Mut: mutation; PPP: pentose phosphate pathway; HBP: hexosamine biosynthesis pathway; FASN: fatty acid synthase; and SCD: stearoyl-CoA desaturase